Genomictree, Inc. engages in the development and supply of diagnostic products for cancer screening and prognosis. Its products include equipment for detection of cancer, diagnostics, and other infectious diseases. The company was founded by Sung-Whan An and Chi-Wang Yoon on October 6, 2000 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company